Genipin inhibits mitochondrial uncoupling protein 2 expression and Ameliorates podocyte injury in diabetic mice

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Qiu, Wenjing ^a   Zhou, Yang ^a   Jiang, Lei ^a   Fang, Li ^a   Chen, Lu ^a   Su, Weifang ^a   Tan, Ruoyun ^a   Zhang, Chen yu ^b   Han, Xiao ^a   Yang, Junwei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GENIPIN; GLUCOSE; MITOCHONDRIAL PROTEIN; PODOCIN; UNCOUPLING PROTEIN 2; WT1 PROTEIN;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DAMAGE; CHINESE MEDICINE; CONTROLLED STUDY; DISEASE COURSE; GLOMERULUS BASEMENT MEMBRANE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PODOCYTE; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES; THICKNESS; UPREGULATION; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ALBUMINURIA; ANIMALS; CHOLAGOGUES AND CHOLERETICS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ENDOPEPTIDASES; GENE EXPRESSION REGULATION; IRIDOIDS; MALE; MEDICINE, CHINESE TRADITIONAL; MICE; PODOCYTES;

MUS;

EID: 84864034725     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041391     Document Type: Article

References (41)

1. Liu S, Wang W, Zhang J, He Y, Yao C, et al. (2002) Prevalence of diabetes and impaired fasting glucose in Chinese adults, China National Nutrition and Health Survey. Prev Chronic Dis 8: A13.
2. Rajpathak SN, Wylie-Rosett J, (2011) High prevalence of diabetes and impaired fasting glucose among Chinese immigrants in New York City. J Immigr Minor Health 13: 181-183.
3. Lee JW, Brancati FL, Yeh HC, (2011) Trends in the prevalence of type 2 diabetes in Asians versus whites: results from the United States National Health Interview Survey, 1997-2008. Diabetes Care 34: 353-357.
4. Lu B, Yang Z, Wang M, Yang Z, Gong W, et al. (2011) High prevalence of diabetic neuropathy in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes Res Clin Pract 88: 289-294.
5. Yang W, Lu J, Weng J, Jia W, Ji L, et al. (2011) Prevalence of diabetes among men and women in China. N Engl J Med 362: 1090-1101.
6. Zhang PP, Ge YC, Li SJ, Xie HL, Li LS, et al. (2011) Renal biopsy in type 2 diabetes: timing of complications and evaluating of safety in Chinese patients. Nephrology (Carlton) 16: 100-105.
7. Langham RG, Kelly DJ, Cox AJ, Thomson NM, Holthofer H, et al. (2002) Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition. Diabetologia 45: 1572-1576.
8. White KE, Bilous RW, Marshall SM, El Nahas M, Remuzzi G, et al. (2002) Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes 51: 3083-3089.
9. Wolf G, Chen S, Ziyadeh FN, (2005) From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 54: 1626-1634.
10. Dai C, Yang J, Bastacky S, Xia J, Li Y, et al. (2004) Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice. J Am Soc Nephrol 15: 2637-2647.
11. Campbell KN, Raij L, Mundel P, (2011) Role of angiotensin II in the development of nephropathy and podocytopathy of diabetes. Curr Diabetes Rev 7: 3-7.
12. Mathieson PW, (2009) Update on the podocyte. Curr Opin Nephrol Hypertens 18: 206-211.
13. Toyoda M, Najafian B, Kim Y, Caramori ML, Mauer M, (2007) Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes 56: 2155-2160.
14. Susztak K, Raff AC, Schiffer M, Bottinger EP, (2006) Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55: 225-233.
15. Dai C, Stolz DB, Kiss LP, Monga SP, Holzman LB, et al. (2009) Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 20: 1997-2008.
16. Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, et al. (2005) Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16: 2941-2952.
17. Deedwania P, (2011) Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating beta-blockers. J Clin Hypertens (Greenwich) 13: 52-59.
18. Executive summary: standards of medical care in diabetes -2011. Diabetes Care 34: S4-10.
19. Baker MK, Simpson K, Lloyd B, Bauman AE, Singh MA, (2011) Behavioral strategies in diabetes prevention programs: a systematic review of randomized controlled trials. Diabetes Res Clin Pract 91: 1-12.
20. Buse JB, (2011) Type 2 diabetes mellitus in 2010: individualizing treatment targets in diabetes care. Nat Rev Endocrinol 7: 67-68.
21. Deb DK, Sun T, Wong KE, Zhang Z, Ning G, et al. (2011) Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes. Kidney Int 77: 1000-1009.
22. Gao Q, Shen W, Qin W, Zheng C, Zhang M, et al. (2011) Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy. Nephrol Dial Transplant 25: 3539-3547.
23. Okada T, Wada J, Hida K, Eguchi J, Hashimoto I, et al. (2006) Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms. Diabetes 55: 1666-1677.
24. Zhang CY, Parton LE, Ye CP, Krauss S, Shen R, et al. (2006) Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity- and high glucose-induced beta cell dysfunction in isolated pancreatic islets. Cell Metab 3: 417-427.
25. Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, et al. (2001) Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 105: 745-755.
26. Qian Y, Feldman E, Pennathur S, Kretzler M, Brosius FC 3rd (2008) From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes 57: 1439-1445.
27. Schena FP, Gesualdo L, (2005) Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 16: S30-33.
28. Wolf G, Ritz E, (2003) Diabetic nephropathy in type 2 diabetes prevention and patient management. J Am Soc Nephrol 14: 1396-1405.
29. Ziyadeh FN, Sharma K, (2003) Overview: combating diabetic nephropathy. J Am Soc Nephrol 14: 1355-1357.
30. Haneda M, Koya D, Isono M, Kikkawa R, (2003) Overview of glucose signaling in mesangial cells in diabetic nephropathy. J Am Soc Nephrol 14: 1374-1382.
31. Mason RM, Wahab NA, (2003) Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14: 1358-1373.
32. Dalla Vestra M, Masiero A, Roiter AM, Saller A, Crepaldi G, et al. (2003) Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes 52: 1031-1035.
33. Zheng S, Carlson EC, Yang L, Kralik PM, Huang Y, et al. (2008) Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy. J Am Soc Nephrol 19: 2077-2085.
34. Davis B, Dei Cas A, Long DA, White KE, Hayward A, et al. (2007) Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia. J Am Soc Nephrol 18: 2320-2329.
35. Eremina V, Cui S, Gerber H, Ferrara N, Haigh J, et al. (2006) Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am Soc Nephrol 17: 724-735.
36. Godel M, Hartleben B, Herbach N, Liu S, Zschiedrich S, et al. (2011) Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest 121: 2197-2209.
37. Dai C, Stolz DB, Bastacky SI, St-Arnaud R, Wu C, et al. (2006) Essential role of integrin-linked kinase in podocyte biology: Bridging the integrin and slit diaphragm signaling. J Am Soc Nephrol 17: 2164-2175.
38. Yang J, Liu Y, (2001) Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159: 1465-1475.
39. Bu X, Zhou Y, Zhang H, Qiu W, Chen L, et al. (2011) Systemic administration of naked plasmid encoding HGF attenuates puromycin aminonucleoside-induced damage of murine glomerular podocytes. Am J Physiol Renal Physiol 301: F784-792.
40. Li Y, Kang YS, Dai C, Kiss LP, Wen X, et al. (2008) Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 172: 299-308.
41. Rico M, Mukherjee A, Konieczkowski M, Bruggeman LA, Miller RT, et al. (2005) WT1-interacting protein and ZO-1 translocate into podocyte nuclei after puromycin aminonucleoside treatment. Am J Physiol Renal Physiol 289: F431-441.